Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

A gene expression profile test to resolve head & neck squamous versus lung squamous cancers.

Lal A, Panos R, Marjanovic M, Walker M, Fuentes E, Kubicek GJ, Henner WD, Buturovic LJ, Halks-Miller M.

Diagn Pathol. 2013 Mar 11;8:44. doi: 10.1186/1746-1596-8-44.

2.

Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.

Kulkarni A, Pillai R, Ezekiel AM, Henner WD, Handorf CR.

Diagn Pathol. 2012 Aug 21;7:110. doi: 10.1186/1746-1596-7-110.

3.

Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.

Talbot SG, Estilo C, Maghami E, Sarkaria IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein R, Viale A, Park BJ, Rusch VW, Singh B.

Cancer Res. 2005 Apr 15;65(8):3063-71.

4.

A gene expression profile test for the differential diagnosis of ovarian versus endometrial cancers.

Lal A, Panos R, Marjanovic M, Walker M, Fuentes E, Kapp DS, Henner WD, Buturovic LJ, Halks-Miller M.

Oncotarget. 2012 Feb;3(2):212-23.

5.

Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.

Pillai R, Deeter R, Rigl CT, Nystrom JS, Miller MH, Buturovic L, Henner WD.

J Mol Diagn. 2011 Jan;13(1):48-56. doi: 10.1016/j.jmoldx.2010.11.001. Epub 2010 Dec 23.

6.

Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.

Lallemant B, Evrard A, Chambon G, Sabra O, Kacha S, Lallemant JG, Lumbroso S, Brouillet JP.

Head Neck. 2010 Dec;32(12):1712-9. doi: 10.1002/hed.21491. Review.

PMID:
20949446
7.

Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

Leong PP, Rezai B, Koch WM, Reed A, Eisele D, Lee DJ, Sidransky D, Jen J, Westra WH.

J Natl Cancer Inst. 1998 Jul 1;90(13):972-7.

8.

Rapid detection of high-level oncogene amplifications in ultrasonic surgical aspirations of brain tumors.

Truong LN, Patil S, Martin SS, LeBlanc JF, Nanda A, Nordberg ML, Beckner ME.

Diagn Pathol. 2012 Jun 12;7:66. doi: 10.1186/1746-1596-7-66.

9.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM.

Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.

10.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
11.

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.

12.

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S.

Mol Med. 2001 Jul;7(7):442-53.

13.

Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.

Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS.

Clin Cancer Res. 2008 Feb 15;14(4):1002-14. doi: 10.1158/1078-0432.CCR-07-1497.

14.

Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.

Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1160-7. doi: 10.1164/rccm.201203-0534OC. Epub 2012 Oct 4.

PMID:
23043084
15.

Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.

Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.

J Pathol. 2008 Mar;214(4):489-97. doi: 10.1002/path.2306.

PMID:
18213732
16.

Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.

Ross JS, Wang K, Rand JV, Sheehan CE, Jennings TA, Al-Rohil RN, Otto GA, Curran JC, Palmer G, Downing SR, Yelensky R, Lipson D, Balasubramanian S, Garcia L, Mahoney K, Ali SM, Miller VA, Stephens PJ.

Am J Surg Pathol. 2014 Feb;38(2):235-8. doi: 10.1097/PAS.0000000000000102.

PMID:
24418857
17.

Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.

Loudig O, Brandwein-Gensler M, Kim RS, Lin J, Isayeva T, Liu C, Segall JE, Kenny PA, Prystowsky MB.

Hum Pathol. 2011 Dec;42(12):1911-22. doi: 10.1016/j.humpath.2011.02.011. Epub 2011 Jun 17.

PMID:
21683979
18.

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG.

Cancer Res. 2006 Aug 15;66(16):8210-8.

19.

Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis.

Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, Reed SG.

Laryngoscope. 2000 Mar;110(3 Pt 1):374-81.

PMID:
10718422
20.

Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.

Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM.

Am J Otolaryngol. 2011 Nov-Dec;32(6):528-36. doi: 10.1016/j.amjoto.2010.11.005. Epub 2011 Feb 24.

PMID:
21353335
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk